Gordon M. Binder - 15 May 2024 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role
Director
Signature
/s/ Gordon M. Binder by Dale A. Sander as Attorney-in-Fact
Issuer symbol
HUMA
Transactions as of
15 May 2024
Net transactions value
+$667,500
Form type
4
Filing time
15 May 2024, 19:24:07 UTC
Previous filing
16 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HUMA Common Stock Purchase $328,500 +50,000 $6.57 50,000 15 May 2024 By the Binder Trust dated 15 July 2003 F1
transaction HUMA Common Stock Purchase $339,000 +50,000 +45% $6.78 160,000 15 May 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $6.44 to $6.59. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 The price is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $6.64 to $6.96. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.